Despite the major role of MAPK pathway in colorectal cancer (CRC) and papillary thyroid cancer (PTC), there are few reports about the prevalence of MAP2K1 mutations in these tumor sites (17, 20–22). The gene discussed is MAP2K1; the disease is neoplasm.